scispace - formally typeset
S

Sherry L. Morissette

Researcher at Boehringer Ingelheim

Publications -  19
Citations -  2527

Sherry L. Morissette is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Crystal structure & COPD. The author has an hindex of 13, co-authored 19 publications receiving 2418 citations. Previous affiliations of Sherry L. Morissette include Chartered Institute of Management Accountants & University of South Florida.

Papers
More filters
Journal ArticleDOI

High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids

TL;DR: The impact of form diversity encompasses issues of stability and bioavailability, as well as development considerations such as process definition, formulation design, patent protection and regulatory control.
Journal ArticleDOI

Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

TL;DR: The results suggest that cocrystals of drug molecules have the possibility of achieving the higher oral bioavailability common for amorphous forms of water-insoluble drugs while maintaining the long-term chemical and physical stability that crystal forms provide.
Journal ArticleDOI

Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization.

TL;DR: Dunitz et al. as mentioned in this paper carried out high-throughput crystallization experiments to comprehensively explore ritonavir form diversity and found a total of five forms: both known forms and three previously unknown forms.
Journal ArticleDOI

Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III.

TL;DR: Three crystal forms of acetaminophen were prepared and characterized using a newly developed high-throughput crystallization platform, CrystalMax, and one structure suggested has a bilayer motif, held together by O-H...O(H) hydrogen bonds, and helps explain the difficulty associated with preparing this form from solution.
Journal ArticleDOI

High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical Compounds

TL;DR: In this article, a survey of crystal form diversity of two test compounds, 1 (an experimental angiotensin II antagonist) and 2 (sertraline HCl, the active drug in Zoloft), has been performed with high-throughput (HT) crystallization.